Trial Profile
Study of DLX 105 in patients with Behcet's disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Aug 2016
Price :
$35
*
At a glance
- Drugs DLX 105 (Primary)
- Indications Behcet's syndrome
- Focus Pharmacokinetics
- 05 Oct 2015 New trial record